Richard Chesworth, D.Phil.
“We have the opportunity to turn drug discovery for neurodegenerative diseases on its head.”
At Third Rock, Richard focuses on drug discovery and development opportunities. Since joining the firm, Richard has been amazed at the talent within TRV and the larger TRV family, and he appreciates that no matter the topic, there is always an expert willing to provide insight. He is especially excited about initiatives at the firm focusing on neurodegenerative diseases, which he believes will revolutionize the way we discover drugs in this therapeutic area, and become the foundation for new exciting therapies that will help patients currently with no options.
Richard has contributed to the research and development programs of nine clinical drug candidates over his career. Outside of the office, Richard enjoys spending time with his rescue dogs, Daphne and Willis, as well as racing cars.